MSBIO, Inc. (KOSDAQ:0013Y0)

Market Cap	263.59B
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	27.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,892,337
Open	13,550.00
Previous Close	13,320.00
Day's Range	9,650.00 - 14,400.00
52-Week Range	7,800.00 - 19,650.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MSBIO

MSBIO, Inc. engages in the developing, manufacturing, and selling products that restores and treats damaged human tissues in South Korea. The company offers allograft tissue products, such as GenerFill H, MYBONE, MS Aminion, and MYDERM. It also provides medical devices, including MYGEN, a low antigenicity collagen injector; MS hydrolifting; MS Collagen, a low antigenicity atelocollagen; and MYGIS, a resorbable collagen membrane for GBR. The company was founded in 2015 and is headquartered in Seongnam-si, South Korea.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 0013Y0

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error